Indications/Uses : Rabeloc 20: Active duodenal & gastric ulcer. H.pylori +ve duodenal ulcers in combination w/ appropriate antibiotics eg, amoxicillin & clarithromycin as part of eradication programme. Symptomatic erosive or ulcerative GERD or non-erosive reflux disease (NERD). Maintenance treatment of healed erosive or ulcerative GERD. Sequential therapy (step-down) from IV rabeprazole Na. Rabeloc IV: Active duodenal or gastric ulcer w/ bleeding or severe erosions. Severe erosive or ulcerative GERD or NERD where patient is unable to take oral PPIs. Stress-induced mucosal injury in critical care. Prevention of acid-aspiration during surgery. Sequential therapy (step-up) from oral rabeprazole.
Indications/Uses : Relief of cough, clogged nose, postnasal drip, headache, body aches & fever associated w/ the common cold, allergic rhinitis, sinusitis, flu & other minor resp tract infections. Helps decongest sinus openings & passages.
Indications/Uses : Risponz 1/Risponz 2/Risponz 3 Schizophrenia & other psychoses; short-term treatment of acute manic or mixed episodes associated w/ bipolar disorder; treatment of irritability associated w/ autistic disorder. Risponz Schizophrenia & moderate to severe manic episodes w/ bipolar disorder. Short-term symptomatic treatment (up to 6 wk) of persistent aggression in conduct disorder in childn 5 yr & adolescent w/ sub-ave intellectual functioning or mental retardation.
Indications/Uses : Treatment of infections due to susceptible organisms including UTI, skin & resp tract infections eg, severe nosocomial pneumonia infections caused by multi-resistant microorganisms.
Indications/Uses : Reduce risk of CV death & heart failure (HF) hospitalization following worsening HF event, in adults w/ symptomatic chronic HF & ejection fraction
Indications/Uses : Management of mild to moderate pain & inflammation in conditions eg, migraine, post-op & dental pain, musculoskeletal & joint disorders (eg, ankylosing spondylitis, OA & RA including juvenile RA), peri-articular disorders (eg, bursitis & tenosynovitis) & soft tissue disorders (eg, sprains & strains). Used to reduce fever.
Indications/Uses : Maintenance treatment of patients w/ COPD (including chronic bronchitis & emphysema); associated dyspnea & for prevention of exacerbations.
Contents : Fe sulfate monohydrate (equiv to 65.73 mg Fe) 200 mg, Na ascorbate [equiv to 100 mg ascorbic acid (vit C)] 112.49 mg, nicotinamide (vit B3) 20 mg, riboflavin phosphate [equiv to 2 mg riboflavin (vit B2)] 2.54 mg, thiamine mononitrate (vit B1) 2 mg, pyridoxine HCl (vit B6) 2 mg, folic acid (vit B9) 400 mcg, cyanocobalamin (vit B12) 10 mcg
Indications/Uses : Adult (>18 yr) w/ bacterial infections eg, acute bacterial sinusitis; acute bacterial exacerbation of chronic bronchitis; community acquired pneumonia; complicated skin & skin structure infections (IV); mild to moderate pelvic inflammatory disease (ie, infections of female upper genital tract, including salpingitis & endometritis) in patient ≥18 yr. Floxsafe IV Complicated intraabdominal infections.
Indications/Uses : Symptomatic relief of OA, RA, ankylosing spondylitis, pain & signs of inflammation associated w/ acute gouty arthritis in adults & adolescents ≥16 yr. Short term treatment of moderate pain associated w/ dental surgery.
Indications/Uses : Prevention of VTE in adults who have undergone elective hip or knee replacement surgery; stroke & systemic embolism in adults w/ non-valvular atrial fibrillation (NVAF), w/ ≥1 risk factors, eg, prior stroke or transient ischaemic attack (TIA); ≥75 yr; HTN; DM; symptomatic heart failure (NYHA Class ≥II). Treatment of DVT & pulmonary embolism (PE), & prevention of recurrent DVT & PE in adults.
Contents : Per Norpriexia FC tab Paracetamol 450 mg, orphenadrine citrate 35 mg. Per Norpriexia Forte FC tab Paracetamol 650 mg, orphenadrine citrate 35 mg
Indications/Uses : Short term treatment of moderate pain, particularly after surgery & fever. Relieve pain due to skeletal muscle spasm. Musculoskeletal & joint disorders.
Indications/Uses : Nosocomial pneumonia; community-acquired pneumonia; complicated skin & soft tissue infections caused by susceptible organisms.
Contents : Per 100 mcg/62.5 mcg/25 mcg DPI Fluticasone furoate 100 mcg, umeclidinium Br 62.5 mcg, vilanterol trifenatate 25 mcg
Indications/Uses : Maintenance treatment to prevent & relieve symptoms associated w/ COPD.
Indications/Uses : Helps improve digestion & lactose malabsorption. Enhance intestinal ecology; natural resistance to intestinal infections.
Indications/Uses : Reduction of fever or relief of pain in common upper resp infection; runny nose, nasal congestion, allergic rhinitis & sinusitis.
Indications/Uses : Dissolution of cholesterol-rich gallstones in patients w/ functioning gallbladders. Primary biliary cirrhosis.
Indications/Uses : Acute & chronic resp tract infections w/ abundant mucus secretions due to acute bronchitis, chronic bronchitis & its exacerbations, pulmonary emphysema, mucoviscidosis & bronchiectasis.
Indications/Uses : Promote intestinal good bacteria, better digestion; enhance body's ability to fight off digestive infection. Help prevent lactose malabsorption.
Indications/Uses : Venous circulation disorders (swollen legs, pain, early morning restless legs) & symptoms due to acute haemorrhoidal attack.
